Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
hepatitis A + B-vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
hepatitis A + B-vaccine til voksne, injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
|
hepatitis A + B-vaccine til børn, i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
|
hepatitis A- + tyfusvaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
hepatitis A-/tyfusvaccine 1440 enheder/25 µg, injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
|
hepatitis A-vaccine injektionsvæske, suspension i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
hepatitis A-vaccine til børn injektionsvæske, suspension i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
|
hepatitis A-virus-vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
hepatitis A-vaccine, inaktiv 720 enheder/0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
|
Hepatitis a vaccine, inactiv 1440elu/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
|
hepatitis A-vaccine, inaktiv 50 enheder suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
|
hepatitis A-vaccine, inaktiv 25 enheder suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
|
Hepatitis a vaccine, inactiv 50unts solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
|
Hepatitis a vaccine, inactiv 25unts solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
|
hepatitis A-vaccine, inaktiv, 1440 enheder/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
|
Hepatitis a vaccine, inactiv 720unt/.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
|
Hepatitis A+typhoid vaccine 160units/25micrograms/1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
|
hepatitis A-vaccine injektionsvæske, suspension i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
|
hepatitis A-vaccine injektionsvæske, suspension i fyldt injektionssprøjte a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
|
hepatitis A- 160 enheder/1ml + tyfusvaccine 25 µg/1 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
|
Administration of first dose of paediatric hepatitis A vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of second dose of hepatitis A vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of third dose of hepatitis A vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of booster dose of vaccine product containing only Hepatitis A virus antigen (procedure) |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of hepatitis A vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Adverse reaction to hepatitis A vaccine |
Causative agent |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Allergy to component of vaccine product containing Hepatitis A virus antigen (finding) |
Causative agent |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
|
1. børnevaccination mod hepatitis A |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
2. børnevaccination mod hepatitis A |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of hepatitis A and typhoid vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of first dose of hepatitis A and B vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of second dose of hepatitis A and B vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of third dose of hepatitis A and B vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of booster dose of vaccine product containing only Hepatitis A and Hepatitis B virus antigens (procedure) |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only Hepatitis A and Hepatitis B virus antigens (procedure) |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of first dose of hepatitis A and typhoid vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of second hepatitis A and typhoid vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
3. børnevaccination mod hepatitis A |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
booster-børnevaccination mod hepatitis A |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of booster dose of vaccine product containing only Hepatitis A virus and Salmonella enterica subspecies enterica serovar Typhi antigens (procedure) |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of booster dose of vaccine product containing only Hepatitis A virus and Salmonella enterica subspecies enterica serovar Typhi antigens (procedure) |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of second dose of hepatitis A and B vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of third dose of hepatitis A and B vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of booster dose of vaccine product containing only Hepatitis A and Hepatitis B virus antigens (procedure) |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
2. børnevaccination mod hepatitis A |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
1. børnevaccination mod hepatitis A |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of booster dose of vaccine product containing only Hepatitis A virus antigen (procedure) |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of first dose of hepatitis A and typhoid vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of first dose of hepatitis A and B vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of second dose of hepatitis A vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only Hepatitis A and Hepatitis B virus antigens (procedure) |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of first dose of paediatric hepatitis A vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of third dose of hepatitis A vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of hepatitis A vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
3. børnevaccination mod hepatitis A |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
booster-børnevaccination mod hepatitis A |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of hepatitis A and typhoid vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of second hepatitis A and typhoid vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
booster-børnevaccination mod hepatitis A |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
3. børnevaccination mod hepatitis A |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of hepatitis A vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of third dose of hepatitis A vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
1. børnevaccination mod hepatitis A |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of second dose of hepatitis A vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
2. børnevaccination mod hepatitis A |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of first dose of paediatric hepatitis A vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of booster dose of vaccine product containing only Hepatitis A virus antigen (procedure) |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Allergy to component of vaccine product containing Hepatitis A virus antigen (finding) |
Causative agent |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
Administration of adult hepatitis A vaccine |
Direct substance |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
hepatitis A-vaccine injektionsvæske, suspension i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
hepatitis A-vaccine injektionsvæske, suspension i fyldt injektionssprøjte a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
1 |
hepatitis A-/tyfusvaccine 1440 enheder/25 µg, injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod hepatitis A-virus |
Inferred relationship |
Some |
2 |